| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 07/19/2001 | WO2001051087A2 Novel treatment for eye disease |
| 07/19/2001 | WO2001050830A2 Dynamised auto fluid therapy |
| 07/19/2001 | WO2000040229A3 Synergistic tumorcidal response induced by histamine |
| 07/19/2001 | US20010008880 Thrombolytic agents and methods of treatment for thrombosis |
| 07/19/2001 | US20010008758 Electrosensitizing red blood cell; applying sound waves |
| 07/19/2001 | US20010008757 Synthetic media for blood components |
| 07/19/2001 | DE10101543A1 Enhancing the antitumor activity of an amygdalin-containing material, especially loquat kernels, comprises roasting the material with far infrared radiation and fermenting it with microorganisms |
| 07/19/2001 | DE10000807A1 Verfahren zur Behandlung eines kosmetischen Mittels durch Bestrahlung mit NIR-Strahlung, sowie dessen Verwendung A method for the treatment of a cosmetic product by means of irradiation with NIR radiation, and its use |
| 07/19/2001 | CA2395567A1 Novel treatment for eye disease |
| 07/18/2001 | EP1116484A2 Treatment of a cosmetic with NIR-rays and its use |
| 07/18/2001 | EP1115412A1 Neuroimmunophilins for selective neuronal radioprotection |
| 07/18/2001 | EP0616508B1 Gas filled liposomes and their use as ultrasonic contrast agents |
| 07/18/2001 | CA2296997A1 Treatment of congestive heart failure |
| 07/17/2001 | US6261281 Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| 07/17/2001 | CA2331167A1 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method for assessing antitumor substance containing amygdalin |
| 07/17/2001 | CA2296822A1 Goldaqua, oxygen-enriched within a magnetic field, magnetically treated water and heavy water/0.1-111 ppm deuterium content/, food-bio and pharmaceutical liquid product, suitable to prevent and cure cancereus and aids diseases and apparatus for preparing these product. |
| 07/12/2001 | WO2000064476A3 Immuno-adjuvant pdt treatment of metastatic tumors |
| 07/12/2001 | WO2000041726A9 Noninvasive vascular therapy |
| 07/12/2001 | WO2000025830A3 Biomimetic elements containing iodine and/or tellurium, the production thereof and their use |
| 07/12/2001 | US20010007666 Destroying endosomal membrane in response to low pH |
| 07/12/2001 | DE19957287A1 Treatment of symptoms associated with loosening of implanted endoprostheses, e.g. pain, by administration of a homeopathic preparation of zinc or a zinc compound, e.g. zinc gluconate |
| 07/11/2001 | EP0731808B1 Nucleosides and oligonucleotides containing boron clusters |
| 07/11/2001 | CN1303393A Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 07/10/2001 | US6258378 Delivery of biologically active substance to target sites in the body of patients |
| 07/05/2001 | WO2000074767A3 Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor |
| 07/05/2001 | WO2000071162A3 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 07/05/2001 | US20010006954 Synthetic DNA comprising a radiation responsive enhancer-promoter operatively linked to a polypeptide encoding region linked to a transcription terminating region; regulating gene expression and inhibiting tumor growth |
| 07/05/2001 | US20010006679 X-ray crystallography reagent |
| 07/04/2001 | EP1113020A2 Nucleosides and oligonucleotides containing boron clusters |
| 07/04/2001 | EP1112748A2 Method and device for transmitting the biological activity of a carrier material as a signal to another carrier material, and for processing said signal, and product thereby obtained |
| 07/04/2001 | CN1302211A Improvements in/or relating to diagnostic/therapeutic agent |
| 07/04/2001 | CN1301573A High energy health water |
| 06/27/2001 | EP1110963A2 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 06/27/2001 | EP1109531A1 Local delivery of medications to the heart |
| 06/27/2001 | EP1109506A1 Improved method for targeted topical treatment of disease |
| 06/27/2001 | EP1109489A1 Pharmaceutically enhanced low-energy radiosurgery |
| 06/27/2001 | EP0862564A4 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 06/26/2001 | US6251644 Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer |
| 06/26/2001 | US6251580 Platelet storage nutrient solution; for use in the purification of platelets |
| 06/26/2001 | US6251365 Magnetite monocrystals and phosphatide membranes |
| 06/26/2001 | US6251127 Dye treatment solution and photodynamic therapy and method of using same |
| 06/20/2001 | EP1107971A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 06/20/2001 | EP1107764A1 Use of solar radiation in the form of ointment, cream, lotion or solution for treating dermatosis |
| 06/20/2001 | EP0773794B1 Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias |
| 06/19/2001 | US6248916 Macromolecular structures for boron neutron-capture therapy |
| 06/19/2001 | US6248734 Use of photodynamic therapy for prevention of secondary cataracts |
| 06/19/2001 | US6248727 Systemically administered diagnostic reagent for visualizing and occluding a blood vessel in a mammal comprising a liposome-encapsulated fluorescent dye releaseable at body temperature, a tissue reactive agent and a carrier |
| 06/19/2001 | CA2136447C Selective cell inactivation in blood |
| 06/14/2001 | WO2001042368A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
| 06/13/2001 | EP0820432B1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 06/13/2001 | CN1299249A Reagent for tumor therapy and/or imaging |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245747 Targeted site specific antisense oligodeoxynucleotide delivery method |
| 06/07/2001 | WO2001040234A1 Porphyrin compound |
| 06/07/2001 | WO2001040233A1 Nitroimidazole-supporting porphyrin complex |
| 06/07/2001 | WO2001040232A1 Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 06/07/2001 | WO2001039764A2 Methods for treating conditions and illnesses associated with abnormal vasculature |
| 06/07/2001 | CA2392989A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| 06/07/2001 | CA2368268A1 Porphyrin compounds |
| 06/07/2001 | CA2360829A1 Nitroimidazole substituted porphyrin complex |
| 06/06/2001 | EP0883695B1 Method and composition for hair removal |
| 06/05/2001 | US6242477 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds |
| 06/01/2001 | CA2291352A1 Method of providing cosmetic/medical therapy |
| 05/31/2001 | WO2001037875A2 Method for bestowing a medicinal or biological relieving effect on an electrically-powered device |
| 05/31/2001 | US20010002275 Providing a nonconductor core, binding plurality of linker molecule to the core, binding precursor comprising a conductive material to the linker, forming shell around the core by depositing precursor additional conductive material |
| 05/31/2001 | US20010002261 Microencapsulated bioactive agents and method of making |
| 05/31/2001 | US20010002251 Intracellular sensitizers for sonodynamic therapy |
| 05/30/2001 | EP0840570A4 Apparatus and method for making gas-filled vesicles of optimal size |
| 05/30/2001 | EP0660712B1 Transcutaneous in vivo activation of photosensitive agents in blood |
| 05/29/2001 | US6239117 Dna sequence encoding protein, expression, treating erectile dysfunction, bladder dysfunction, and other smooth muscle disorders. |
| 05/29/2001 | US6238426 Real-time monitoring of photodynamic therapy over an extended time |
| 05/29/2001 | CA2127530C Metal complexes of water soluble texaphyrins |
| 05/26/2001 | CA2291559A1 Alternating current prepared medicament and uses thereof |
| 05/25/2001 | WO2001036007A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 05/25/2001 | WO2001035997A2 Use of low-dose pdt to inhibit restenosis |
| 05/25/2001 | WO2001035996A2 Use of pdt to inhibit intimal hyperplasia |
| 05/25/2001 | WO2001035952A2 Radiosensitization of human glioblastoma cells by quinazoline compounds |
| 05/25/2001 | WO2001035867A2 Ophthalmologic implant |
| 05/25/2001 | CA2391389A1 Use of pdt to inhibit intimal hyperplasia |
| 05/25/2001 | CA2388844A1 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
| 05/24/2001 | US20010001791 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
| 05/23/2001 | EP1100576A1 Synergism of photodynamic and electropermeation effects on cell vitality as a novel cytotoxic agent |
| 05/23/2001 | EP1100394A1 Treatment of pigmented tissues using optical energy |
| 05/23/2001 | EP1100385A1 Ultrasound assembly for use with a catheter |
| 05/23/2001 | EP1100366A1 Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea |
| 05/23/2001 | DE19953637A1 Neutron-activated radioactive material comprising rare earth compound, preferably thulium oxide, in matrix, e.g. of polymer, useful in medicine, e.g. for producing restenosis-preventing stents |
| 05/23/2001 | DE19953636A1 Neutron-activated radioactive material comprising rare earth compound, preferably thulium oxide, in matrix, e.g. of polymer, useful in medicine, e.g. for producing restenosis-preventing stents |
| 05/23/2001 | CN1296413A Composition and method for modulating cytokine release in response to genotoxic agents |
| 05/22/2001 | US6235508 Mixing virus or cell mixture containing psoralen or coumarin compound with blocking agent like n-acetylcysteine, then irradiating the mixture; reduces ring opening reaction |
| 05/17/2001 | WO2001034199A2 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | WO2001034198A2 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | WO2001034197A2 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | WO2001034194A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy |
| 05/17/2001 | WO2000032121A9 Reduction, elimination, or stimulation of hair growth |
| 05/17/2001 | DE19955836C1 Ophthalmologisches Implantat Ophthalmologic implant |
| 05/17/2001 | CA2390412A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy |
| 05/16/2001 | EP1098641A1 Chemically induced intracellular hyperthermia |
| 05/16/2001 | CN1295465A Quinolone-containing liposome composition |
| 05/15/2001 | USRE37180 Photochemotherapeutical obstruction of newly-formed blood vessels |